SCHEMBL1633588

SCHEMBL1633588

CCN1CCC(Oc2ccc3cnc(Nc4cc(OC)cc(OC)c4)nc3c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WEE1 P30291 1/20 0.43
PLK1 P53350 1/20 0.43
CCNA2 P20248 4/20 0.42
CDK2 P24941 4/20 0.42
CDK7 P50613 4/20 0.42
CCNH P51946 4/20 0.42
MNAT1 P51948 4/20 0.42
CCNK O75909 3/20 0.42
CDK12 Q9NYV4 3/20 0.42
CHEK1 O14757 1/20 0.42
BRD4 O60885 1/20 0.41
FGFR1 P11362 1/20 0.41
FGFR4 P22455 1/20 0.41
KDR P35968 1/20 0.41
NUAK1 O60285 1/20 0.41
CDK4 P11802 3/20 0.41
CCND3 P30281 2/20 0.41
CCND1 P24385 2/20 0.41
CCND2 P30279 1/20 0.41
CDK6 Q00534 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634267 0.89 CDK4 (0.50) CCNA2CDK2BRD4CDK4CCND1
SCHEMBL1634242 0.86 HRH3 (0.44) CCNA2CDK2CDK7CCNHMNAT1
SCHEMBL1632083 0.84 IKBKB (0.47) BRD4
SCHEMBL12724903 0.83 CDK4 (0.47) CCNA2CDK2BRD4CDK4CCND1
SCHEMBL12724898 0.81 HRH3 (0.43) CCNA2CDK2CDK7CCNHMNAT1
SCHEMBL2476354 0.79 HRH3 (0.44) CCNA2CDK2CDK7CCNHMNAT1
SCHEMBL1632964 0.78 USP2 (0.49) CCNA2CDK2BRD4LMNA
SCHEMBL13498327 0.78 IKBKB (0.43) CHEK1BRD4FGFR1FGFR4KDR
SCHEMBL1635190 0.76 SYK (0.49) CDK2CHEK1KDRCDK4
SCHEMBL1634175 0.75 SYK (0.53) CCNA2CDK2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed